Mural Oncology Future Growth
Future criteria checks 0/6
Mural Oncology is forecast to grow earnings and revenue by 14.9% and 68.1% per annum respectively. EPS is expected to grow by 35.5% per annum. Return on equity is forecast to be -63.8% in 3 years.
Key information
14.9%
Earnings growth rate
35.5%
EPS growth rate
| Biotechs earnings growth | 28.3% |
| Revenue growth rate | 68.1% |
| Future return on equity | -63.8% |
| Analyst coverage | Low |
| Last updated | 13 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Here's Why We're Watching Mural Oncology's (NASDAQ:MURA) Cash Burn Situation
Nov 26
Here's Why We're A Bit Worried About Mural Oncology's (NASDAQ:MURA) Cash Burn Situation
Jul 17We're Keeping An Eye On Mural Oncology's (NASDAQ:MURA) Cash Burn Rate
Mar 28Recent Spin Mural Oncology At An Attractive Discount To Cash And Portfolio Value
Mar 04Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 15 | -122 | -92 | -114 | 2 |
| 12/31/2025 | N/A | -126 | -121 | -118 | 1 |
| 12/31/2024 | N/A | -128 | -142 | -129 | 1 |
| 9/30/2024 | N/A | -154 | -141 | -139 | N/A |
| 6/30/2024 | N/A | -173 | -162 | -160 | N/A |
| 3/31/2024 | N/A | -192 | -179 | -176 | N/A |
| 12/31/2023 | N/A | -207 | -198 | -194 | N/A |
| 9/30/2023 | N/A | -196 | -192 | -189 | N/A |
| 6/30/2023 | N/A | -196 | -180 | -176 | N/A |
| 3/31/2023 | N/A | -191 | -182 | -178 | N/A |
| 12/31/2022 | N/A | -190 | -174 | -169 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MURA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: MURA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: MURA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: MURA is forecast to have no revenue next year.
High Growth Revenue: MURA is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MURA is forecast to be unprofitable in 3 years.